Dr. Buffington Discusses Prostate Cancer Screening

Philip J. Buffington, MD
Published: Thursday, Jan 12, 2017



Philip J. Buffington, MD, chief medical officer, The Urology Group, discusses effective prostate cancer screening methods and when to use active surveillance.

Screening for prostate cancer should be done in a smart and efficient way, explains Buffington. Active surveillance has become an important step of determining treatment. Over the last 5 years, the use of active surveillance has increased.

According to Buffington, the amount of procedures a physician completes is not going to be as important as practicing smart medicine, spending a smaller amount of healthcare money, and giving better overall care.



Philip J. Buffington, MD, chief medical officer, The Urology Group, discusses effective prostate cancer screening methods and when to use active surveillance.

Screening for prostate cancer should be done in a smart and efficient way, explains Buffington. Active surveillance has become an important step of determining treatment. Over the last 5 years, the use of active surveillance has increased.

According to Buffington, the amount of procedures a physician completes is not going to be as important as practicing smart medicine, spending a smaller amount of healthcare money, and giving better overall care.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 1st Annual International Congress of Oncology Pathology™: Towards Harmonization of Pathology and Oncology StandardsAug 30, 20182.0
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Publication Bottom Border
Border Publication
x